This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
$2999
The global personalized cancer vaccines market is the industry involved in the development, production, and distribution of vaccines designed to treat cancer on an individualized or personalized basis. These vaccines are tailored to target specific cancer cells or antigens unique to a particular patient's tumor. Personalized cancer vaccines are part of the broader field of immunotherapy, which harnesses the patient's immune system to recognize and attack cancer cells.
Global Personalized Cancer Vaccines Market, By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukaemia, Prostate Cancer, Cervical Cancer and Glioblastoma), Mechanism of Action Type (Tumour-associated Antigens (TAAs), Tumour-specific Antigens (TSAs), Somatic Mutations in Cancer Pharmacogenomics, Pharmacogenomics towards Genomic Polymorphism), Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines and Viral Vector and DNA Cancer Vaccines), Bio-maker Type (Pharmacogenomics, Prognostic and Predictive Biomarkers, Immune Checkpoint Biomarkers and Others), Treatment Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Route of Administration (Injectable and Others), End-Users (Hospitals, Homecare, Specialty Clinics and Others) – Industry Trends and Forecast to 2030.
Global Personalized Cancer Vaccines Market Scope
The global personalized cancer vaccines market is segmented on the basis of
Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukaemia
Prostate Cancer
Cervical Cancer
Glioblastoma
Mechanism of Action Type
Tumour-associated Antigens (TAAs)
Tumour-specific Antigens (TSAs)
Somatic Mutations in Cancer Pharmacogenomics
Pharmacogenomics towards Genomic Polymorphism
Technology
Dendritic Cells (DC) Cancer Vaccines
Recombinant Cancer Vaccines
Antigen/Adjuvant Cancer Vaccines
Viral Vector and DNA Cancer Vaccines
Bio-Maker Type
Pharmacogenomics
Prognostic and Predictive Biomarkers
Immune Checkpoint Biomarkers
Others
Treatment Type
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Route of Administration
Injectables
Others
End Users
Hospitals
Homecare
Specialty Clinics
Others
RELATED PRODUCTS
Sciinov Insights analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030.
Market Research analyses that the veterinary-animal vaccines market, which was USD 10.69 billion in 2022, would rise to USD 18.23 billion by 2030 and is expected to undergo a CAGR of 6.9% during the forecast period from 2023 to 2030.
The vaccines market is segmented on the basis of composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel.